VOYA Investment Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.44M | Sell |
44,296
-262,433
| -86% | -$8.53M | ﹤0.01% | 1420 |
|
2025
Q1 | $11.6M | Buy |
306,729
+5,169
| +2% | +$195K | 0.01% | 693 |
|
2024
Q4 | $24.7M | Sell |
301,560
-2,319
| -0.8% | -$190K | 0.03% | 476 |
|
2024
Q3 | $34.7M | Buy |
303,879
+15,873
| +6% | +$1.81M | 0.04% | 407 |
|
2024
Q2 | $21.7M | Buy |
288,006
+98,338
| +52% | +$7.43M | 0.02% | 521 |
|
2024
Q1 | $13M | Buy |
189,668
+5,791
| +3% | +$396K | 0.01% | 667 |
|
2023
Q4 | $11.5M | Buy |
183,877
+1,384
| +0.8% | +$86.9K | 0.01% | 696 |
|
2023
Q3 | $9.3M | Buy |
182,493
+20,240
| +12% | +$1.03M | 0.01% | 721 |
|
2023
Q2 | $8.1M | Buy |
162,253
+119,464
| +279% | +$5.97M | 0.01% | 803 |
|
2023
Q1 | $1.6M | Hold |
42,789
| – | – | ﹤0.01% | 1440 |
|
2022
Q4 | $2.05M | Buy |
42,789
+22,172
| +108% | +$1.06M | ﹤0.01% | 1317 |
|
2022
Q3 | $495K | Buy |
20,617
+858
| +4% | +$20.6K | ﹤0.01% | 2031 |
|
2022
Q2 | $430K | Buy |
19,759
+3,738
| +23% | +$81.3K | ﹤0.01% | 1925 |
|
2022
Q1 | $387K | Hold |
16,021
| – | – | ﹤0.01% | 2050 |
|
2021
Q4 | $381K | Buy |
16,021
+321
| +2% | +$7.63K | ﹤0.01% | 2170 |
|
2021
Q3 | $398K | Hold |
15,700
| – | – | ﹤0.01% | 2187 |
|
2021
Q2 | $353K | Buy |
15,700
+3,474
| +28% | +$78.1K | ﹤0.01% | 2296 |
|
2021
Q1 | $241K | Buy |
12,226
+4,528
| +59% | +$89.3K | ﹤0.01% | 2436 |
|
2020
Q4 | $205K | Buy |
7,698
+1,845
| +32% | +$49.1K | ﹤0.01% | 2408 |
|
2020
Q3 | $289K | Sell |
5,853
-200,469
| -97% | -$9.9M | ﹤0.01% | 1970 |
|
2020
Q2 | $6.52M | Buy |
+206,322
| New | +$6.52M | 0.02% | 663 |
|